Fibromyalgia: current diagnosis and management

References

• Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum.33(2), 160–172 (1990).
   PubMed Web of Science ®Google Scholar
• Buskila D, Press J, Gedalia A et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J. Rheumatol.20(2), 368–370 (1993).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum.38(1), 19–28 (1995).
   PubMed Web of Science ®Google Scholar
• Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann. Rheum. Dis.60(11), 1040–1045 (2001).
   PubMed Web of Science ®Google Scholar
• White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J. Rheumatol.26(7), 1577–1585 (1999).
   PubMed Web of Science ®Google Scholar
• McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract. Res. Clin. Rheumatol.21(3), 403–425 (2007).
   PubMed Web of Science ®Google Scholar
• Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br. J. Rheumatol.37(5), 491–495 (1998).
   PubMedGoogle Scholar
• Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int. J. Clin. Pract.62(1), 115–126 (2008).
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int. J. Clin. Pract.61(9), 1498–1508 (2007).
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet. Disord.8, 27 (2007).
   PubMed Web of Science ®Google Scholar
• Strusberg I, Mendelberg RC, Serra HA, Strusberg AM. Influence of weather conditions on rheumatic pain. J. Rheumatol.29(2), 335–338 (2002).
   PubMed Web of Science ®Google Scholar
• Yunus M. Symptoms and signs of fibromyalgia syndrome: an overview. In: Fibromyalgia and Other Central Syndromes. Wallace DJ (Ed.). Lippincott Williams and Wilkins, PA, USA 125–132 (2005).
   Google Scholar
• Guymer EK, Clauw DJ. Treatment of fatigue in fibromyalgia. Rheum. Dis. Clin. North Am.28(2), 367–378 (2002).
   PubMed Web of Science ®Google Scholar
• Anch AM, Lue FA, MacLean AW, Moldofsky H. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can. J. Psychol.45(2), 179–184 (1991).
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Alvarez-Horine S. Disordered sleep and sleep-related daytime functioning in fibromyalgia syndrome. Program of Abstracts of the Annual European League Against Rheumatism Congress, Paris, France (2008) (Abstract 380).
   Google Scholar
• Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann. Rheum. Dis.56(4), 268–271 (1997).
   PubMed Web of Science ®Google Scholar
• Granges G, Littlejohn GO. A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J. Rheumatol.20(2), 344–351 (1993).
   PubMed Web of Science ®Google Scholar
• Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ312(7042), 1339 (1996).
   PubMed Web of Science ®Google Scholar
• Epstein SA, Kay G, Clauw D et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics40(1), 57–63 (1999).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Hudson JI, Hess EV et al. Family study of fibromyalgia. Arthritis Rheum.50(3), 944–952 (2004).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J. Clin. Psychiatry67(8), 1219–1225 (2006).
   PubMed Web of Science ®Google Scholar
• Malt EA, Berle JE, Olafsson S, Lund A, Ursin H. Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls. J. Psychosom. Res.49(5), 285–289 (2000).
   PubMed Web of Science ®Google Scholar
• Buskila D, Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr. Pain Headache Rep.11(5), 333–338 (2007).
   PubMedGoogle Scholar
• Staud R. Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res. Ther.8(3), 208 (2006).
   PubMed Web of Science ®Google Scholar
• Russell IJ, Orr MD, Littman B et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum.37(11), 1593–1601 (1994).
   PubMed Web of Science ®Google Scholar
• Nielsen LA, Henriksson KG. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Pract. Res. Clin. Rheumatol.21(3), 465–480 (2007).
   PubMed Web of Science ®Google Scholar
• Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol. Sci.25(12), 613–617 (2004).
   PubMed Web of Science ®Google Scholar
• Buskila D, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J. Rheumatol.24(5), 941–944 (1997).
   PubMed Web of Science ®Google Scholar
• Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics8(1), 67–74 (2007).
   PubMed Web of Science ®Google Scholar
• Diatchenko L, Slade GD, Nackley AG et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet.14(1), 135–143 (2005).
   PubMed Web of Science ®Google Scholar
• Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol. Int.23(3), 104–107 (2003).
   PubMed Web of Science ®Google Scholar
• Annemans L, Wessely S, Spaepen E et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum.58(3), 895–902 (2008).
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Fibromyalgia: update on mechanisms and management. J. Clin. Rheumatol.13(2), 102–109 (2007).
   PubMed Web of Science ®Google Scholar
• Sandstrom MJ, Keefe FJ. Self-management of fibromyalgia: the role of formal coping skills training and physical exercise training programs. Arthritis Care Res.11(6), 432–447 (1998).
   PubMed Web of Science ®Google Scholar
• Buckelew SP, Huyser B, Hewett JE et al. Self-efficacy predicting outcome among fibromyalgia subjects. Arthritis Care Res.9(2), 97–104 (1996).
   PubMed Web of Science ®Google Scholar
• Carville SF, Arendt-Nielsen S, Bliddal H et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann. Rheum. Dis.67, 536–541 (2008).
   PubMed Web of Science ®Google Scholar
• Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst. Rev.4, CD003786 (2007).
   PubMed Web of Science ®Google Scholar
• Mannerkorpi K, Henriksson C. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract. Res. Clin. Rheumatol.21(3), 513–534 (2007).
   PubMed Web of Science ®Google Scholar
• Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA292(19), 2388–2395 (2004).
   PubMed Web of Science ®Google Scholar
• Rossy LA, Buckelew SP, Dorr N et al. A meta-analysis of fibromyalgia treatment interventions. Ann. Behav. Med.21(2), 180–191 (1999).
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Dobkin PL, Bernatsky S et al. Medication non-adherence in women with fibromyalgia. Rheumatology (Oxf.)43(5), 648–654 (2004).
   PubMed Web of Science ®Google Scholar
• Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central µ-opioid receptor availability in fibromyalgia. J. Neurosci.27(37), 10000–10006 (2007).
   PubMed Web of Science ®Google Scholar
• Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J. Clin. Rheumatol.6(5), 250–257 (2000).
   PubMed Web of Science ®Google Scholar
• Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am. J. Med.114(7), 537–545 (2003).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum.43(2), 378–385 (2000).
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Fibromyalgia. In: Rheumatology (4th ESdition). Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (Eds). Mosby–Elsevier, PA, USA 701–711 (2008).
   Google Scholar
• O’Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J. Gen. Intern. Med.15(9), 659–666 (2000).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Keck PE, Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics41(2), 104–113 (2000).
   PubMed Web of Science ®Google Scholar
• Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann. Pharmacother.37(11), 1561–1565 (2003).
   PubMed Web of Science ®Google Scholar
• Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose? Curr. Pharm. Des.12(1), 3–9 (2006).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum.50(9), 2974–2984 (2004).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Rosen A, Pritchett YL et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain119(1–3), 5–15 (2005).
   PubMed Web of Science ®Google Scholar
• Gendreau RM, Thorn MD, Gendreau JF et al. Efficacy of milnacipran in patients with fibromyalgia. J. Rheumatol.32(10), 1975–1985 (2005).
   PubMed Web of Science ®Google Scholar
• Clauw D, Mease P, Palmer R, Thacker K, Gendreau RM. Milnacipran for the treatment of fibromyalgia: a 15-week, randomized, double-blind, placebo-controlled trial. Program of Abstracts of the 9th Annual European League Against Rheumatism Congress. Paris, France (2008) (Abstract 366).
   Google Scholar
• Arnold L, Goldenberg D, Clauw D, Palmer R, Mease P, Gendreau RM. One-year durability of response to milnacipran treatment in fibromyalgia. Program of Abstracts of the 9th Annual European League Against Rheumatism Congress. Paris, France (2008) (Abstract 359).
   Google Scholar
• Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br. J. Rheumatol.37(12), 1279–1286 (1998).
   PubMedGoogle Scholar
• Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia – a randomized, double-blind, placebo-controlled study. Eur. J. Pain4(1), 27–35 (2000).
   PubMed Web of Science ®Google Scholar
• Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain61(3), 445–449 (1995).
   PubMed Web of Science ®Google Scholar
• Spath M, Stratz T, Neeck G et al. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand. J. Rheumatol.33(4), 267–270 (2004).
   PubMed Web of Science ®Google Scholar
• Farber L, Stratz TH, Bruckle W et al. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int. J. Clin. Pharmacol. Res.21(1), 1–13 (2001).
   PubMedGoogle Scholar
• Wood PB, Schweinhardt P, Jaeger E et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci.25(12), 3576–3582 (2007).
   PubMed Web of Science ®Google Scholar
• Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum.52(8), 2495–2505 (2005).
   PubMed Web of Science ®Google Scholar
• DeMaria Jr S, Hassett AL, Sigal LH. N-methyl-D-aspartate receptor-mediated chronic pain: new approaches to fibromyalgia syndrome etiology and therapy. J. Musculoskel. Pain15(2), 33–44 (2007).
   Web of Science ®Google Scholar
• Graven-Nielsen T, Aspegren Kendall S, Henriksson KG et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain85(3), 483–491 (2000).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O’Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain132(3), 237–251 (2007).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JPJ et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology60(8), 1274–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology63(11), 2104–2110 (2004).
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum.52(4), 1264–1273 (2005).
   PubMed Web of Science ®Google Scholar
• Mease PJ, Russell IJ, Arnold LM et al. A randomized, double-blind, placebo-controlled, Phase III trial of pregabalin in the treatment of patients with fibromyalgia. J. Rheumatol.35(3), 502–514 (2008).
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Mease PJ, Simpson SL et al. Fibromyalgia Relapse Evaluation and Efficacy for Durability of Meaningful Relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain136(3), 419–431 (2008).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med.8(8), 633–638 (2007).
   PubMed Web of Science ®Google Scholar
• Arnold L, Leon T, Whalen E, Pauer L, Zeiher B, Barrett J. Treatment with pregabalin is associated with improvement in pain regardless of baseline symptoms of anxiety or depression. Program of Abstracts of the Annual European League Against Rheumatism Congress. Paris, France (2008) (Abstract 358).
   Google Scholar
• Barrett J, Russell IJ, Pauer L, Whalen E, Leon T, Zeiher B. The effect of pregabalin treatment on changes in pain and sleep quality in fibromyalgia patients. Program of Abstracts of the Annual European League Against Rheumatism Congress. Paris, France (2008) (Abstract 362).
   Google Scholar
• Arnold LM, Goldenberg DL, Stanford SB et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum.56(4), 1336–1344 (2007).
   PubMed Web of Science ®Google Scholar
• Passard A, Attal N, Benadhira R et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain130(Pt 10), 2661–2670 (2007).
   PubMed Web of Science ®Google Scholar
• Sampson SM, Rome JD, Rummans TA. Slow-frequency rTMS reduces fibromyalgia pain. Pain Med.7(2), 115–118 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas AW, Graham K, Prato FS et al. A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain. Pain Res. Manag.12(4), 249–258 (2007).
   PubMed Web of Science ®Google Scholar